Sunday, May 26, 2013

Carol Bradley Bursack's Posts

High Blood Sugar Levels May Increase Alzheimer’s Risk, Study Shows

Research has repeatedly shown that people with diabetes have an increased risk of developing Alzheimer’s disease. Additionally, some studies have demonstrated that intra-nasal insulin, sometimes used to treat diabetes, may help improve memory in those already diagnosed with Alzheimer’s disease. This background of knowledge prompted a... Read moreChevron

Vitamins B12, B6 and Folic Acid Shown to Slow Alzheimer’s in Study

Could a combination of the vitamins B12, B6 and folic acid be first effective “drug” to slow down the progression of Alzheimer’s disease? The concept looks promising. The Proceedings of the National Academy of Sciences recently published information about a study on aging volunteers that has demonstrated how this combination of B... Read moreChevron

Leukemia Drug May Stop Dementia Related Plaque Buildup

An existing drug already used to treat leukemia has shown promise as a treatment for neurological diseases such as Lewy body dementia, Alzheimer’s disease and Parkinson’s disease. Researchers from Georgetown University successfully used small doses of the drug nilotinibin in experiments using mice.  This drug, which is used to... Read moreChevron

Choosing a Care Facility? Listen To Your Gut

People often ask what to look for when choosing an assisted living facility or a nursing home for a loved one. There are grading sites such as the Medicare Nursing Home Guide, found on Medicare.gov, and I suggest you use them. However, there are many things that go into good care that can’t be measured on a chart. In order to see the heart... Read moreChevron

Alzheimer’s Treatment Fails in Wider Study

Less than a year ago, I wrote about the promising results in an Alzheimer’s trial of an infusion called Gammagard. A story on CBSNews.com then reported that the experimental drug had been shown to halt the mental decline in some patients. Admittedly, this was a small study, but the results were exciting.     Unfortunately, an... Read moreChevron